semaglutide advisory committee Full SELECT Results Affirm CV Risk Reduction With in Nondiabetics Cardiovascular Outcomes, Safety, and Tolerability

Consulting with a healthcare professional is crucial for personalized recommendations based on individual needs and fitness goals

This condition primarily arises from an imbalance between muscle protein synthesis and degradation, alongside reduced force-generating capacity, often secondary to neuropathy, myofibrillar disruption, sarcoplasmic reticulum (SR) impairment, altered excitability and mitochondrial dysfunction (68)

While the benefits of the weight loss associated with GLP-1 agonist therapy can no longer be denied, it remains the case that a significant amount of that weight loss comes from loss of muscle

GLP-1s can present challenges such as gastrointestinal side effects, risk of nutrient deficiencies, and muscle and bone loss, but nutrition therapy can help, said Dr